Compound formula for supplying nutrition to eyes to protect eyesight and preparation method thereof

Abstract

The invention discloses a compound formula for supplying nutrition to eyes to protect eyesight. The compound formula comprises, by weight, 3%-6% of lutein ester microcapsule powder, 3%-7% of blueberry extract, 15%-25% of purple perilla seed oil microcapsule powder, 1%-3% of zeaxanthin microcapsule powder, 25%-35% of maltodextrin, 12%-20% of vegetable oil, 8%-12% of milk powder, 0.5%-1% of silicon dioxide, 3%-5% of food essence and 0.1%.-0.2%. of sucralose. By means of the compound formula, not only is the problem of nutrition which needs to be supplemented to the eyes solved, but also the problem of greatly increasing the absorption conversion rate is solved.

Description

technical field [0001] The invention belongs to the field of preparing nutritional medicines, and in particular relates to a compound formula for providing eye nutrition and protecting eyesight and a preparation method thereof. Background technique [0002] At present, while electronic devices occupy the visual life of most of us, eyesight has also become a distressing thing for many people, whether it is a student who uses his eyes excessively, or an office worker who faces the computer for more than 8 hours a day, or is on the Internet. Elderly people of all ages have more or less uncomfortable symptoms such as sore eyes, fatigue, pain, and tearing. [0003] The above symptoms can be roughly divided into two kinds of exogenous and endogenous injuries. Exogenous factors include the direct damage to the eyes caused by blue-violet light released by various electronic devices, visual fatigue caused by facing the computer without rest for a long time, dry eyes caused by wind, ...

AI Technical Summary

Problems solved by technology

So, how can we effectively prevent and alleviate it? Many people have done eye exercises and supplemented with vitamins, but the effect is not obvious

There are also products made of lutein on the market, such as tablets and capsules, which have a certain effect on eye protection, but they have poor light and heat stability, poor gastric acid resistance, and are prone to degradation. During the absorption process in the human small intestine, the bioavailability is low, and the absorption conversion rate is only about 60%.